1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Macular Degeneration 1.4.3 Diabetic Macular Edema 1.4.4 Diabetic Retinopathy 1.4.5 Retinal Vein Occlusion 1.5 Market by Application 1.5.1 Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Retinal Disease Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Retinal Disease Therapeutics Industry 1.6.1.1 Retinal Disease Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Retinal Disease Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Retinal Disease Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Retinal Disease Therapeutics Market Perspective (2015-2026) 2.2 Retinal Disease Therapeutics Growth Trends by Regions 2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Retinal Disease Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Retinal Disease Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Retinal Disease Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Retinal Disease Therapeutics Players by Market Size 3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Retinal Disease Therapeutics Market Concentration Ratio 3.2.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2019 3.3 Retinal Disease Therapeutics Key Players Head office and Area Served 3.4 Key Players Retinal Disease Therapeutics Product Solution and Service 3.5 Date of Enter into Retinal Disease Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2021-2026) 5 Retinal Disease Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Retinal Disease Therapeutics Market Size by Application (2015-2020) 5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Retinal Disease Therapeutics Market Size (2015-2020) 6.2 Retinal Disease Therapeutics Key Players in North America (2019-2020) 6.3 North America Retinal Disease Therapeutics Market Size by Type (2015-2020) 6.4 North America Retinal Disease Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Retinal Disease Therapeutics Market Size (2015-2020) 7.2 Retinal Disease Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Retinal Disease Therapeutics Market Size by Type (2015-2020) 7.4 Europe Retinal Disease Therapeutics Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2015-2020) 8.2 Retinal Disease Therapeutics Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2015-2020) 8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Merck 9.1.1 Merck Company Details 9.1.2 Merck Business Overview and Its Total Revenue 9.1.3 Merck Retinal Disease Therapeutics Introduction 9.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2015-2020)) 9.1.5 Merck Recent Development 9.2 Novartis 9.2.1 Novartis Company Details 9.2.2 Novartis Business Overview and Its Total Revenue 9.2.3 Novartis Retinal Disease Therapeutics Introduction 9.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2015-2020) 9.2.5 Novartis Recent Development 9.3 Allergan 9.3.1 Allergan Company Details 9.3.2 Allergan Business Overview and Its Total Revenue 9.3.3 Allergan Retinal Disease Therapeutics Introduction 9.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2015-2020) 9.3.5 Allergan Recent Development 9.4 Roche 9.4.1 Roche Company Details 9.4.2 Roche Business Overview and Its Total Revenue 9.4.3 Roche Retinal Disease Therapeutics Introduction 9.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2015-2020) 9.4.5 Roche Recent Development 9.5 Regeneron 9.5.1 Regeneron Company Details 9.5.2 Regeneron Business Overview and Its Total Revenue 9.5.3 Regeneron Retinal Disease Therapeutics Introduction 9.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2015-2020) 9.5.5 Regeneron Recent Development 9.6 Santen 9.6.1 Santen Company Details 9.6.2 Santen Business Overview and Its Total Revenue 9.6.3 Santen Retinal Disease Therapeutics Introduction 9.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2015-2020) 9.6.5 Santen Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Retinal Disease Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Retinal Disease Therapeutics Revenue Table 3. Ranking of Global Top Retinal Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Macular Degeneration Table 6. Key Players of Diabetic Macular Edema Table 7. Key Players of Diabetic Retinopathy Table 8. Key Players of Retinal Vein Occlusion Table 9. COVID-19 Impact Global Market: (Four Retinal Disease Therapeutics Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Retinal Disease Therapeutics Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Retinal Disease Therapeutics Players to Combat Covid-19 Impact Table 14. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Retinal Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Retinal Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Retinal Disease Therapeutics Market Share by Regions (2015-2020) Table 18. Global Retinal Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Retinal Disease Therapeutics Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Retinal Disease Therapeutics Market Growth Strategy Table 24. Main Points Interviewed from Key Retinal Disease Therapeutics Players Table 25. Global Retinal Disease Therapeutics Revenue by Players (2015-2020) (Million US$) Table 26. Global Retinal Disease Therapeutics Market Share by Players (2015-2020) Table 27. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2019) Table 28. Global Retinal Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Retinal Disease Therapeutics Product Solution and Service Table 31. Date of Enter into Retinal Disease Therapeutics Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 34. Global Retinal Disease Therapeutics Market Size Share by Type (2015-2020) Table 35. Global Retinal Disease Therapeutics Revenue Market Share by Type (2021-2026) Table 36. Global Retinal Disease Therapeutics Market Size Share by Application (2015-2020) Table 37. Global Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. Global Retinal Disease Therapeutics Market Size Share by Application (2021-2026) Table 39. North America Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$) Table 40. North America Key Players Retinal Disease Therapeutics Market Share (2019-2020) Table 41. North America Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. North America Retinal Disease Therapeutics Market Share by Type (2015-2020) Table 43. North America Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. North America Retinal Disease Therapeutics Market Share by Application (2015-2020) Table 45. Europe Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Retinal Disease Therapeutics Market Share (2019-2020) Table 47. Europe Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. Europe Retinal Disease Therapeutics Market Share by Type (2015-2020) Table 49. Europe Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. Europe Retinal Disease Therapeutics Market Share by Application (2015-2020) Table 51. Asia-Pacific Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$) Table 52. Asia-Pacific Key Players Retinal Disease Therapeutics Market Share (2019-2020) Table 53. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Asia-Pacific Retinal Disease Therapeutics Market Share by Type (2015-2020) Table 55. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Asia-Pacific Retinal Disease Therapeutics Market Share by Application (2015-2020) Table 57. Merck Company Details Table 58. Merck Business Overview Table 59. Merck Product Table 60. Merck Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 61. Merck Recent Development Table 62. Novartis Company Details Table 63. Novartis Business Overview Table 64. Novartis Product Table 65. Novartis Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 66. Novartis Recent Development Table 67. Allergan Company Details Table 68. Allergan Business Overview Table 69. Allergan Product Table 70. Allergan Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 71. Allergan Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche Product Table 75. Roche Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 76. Roche Recent Development Table 77. Regeneron Company Details Table 78. Regeneron Business Overview Table 79. Regeneron Product Table 80. Regeneron Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 81. Regeneron Recent Development Table 82. Santen Company Details Table 83. Santen Business Overview Table 84. Santen Product Table 85. Santen Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$) Table 86. Santen Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Macular Degeneration Features Figure 3. Diabetic Macular Edema Features Figure 4. Diabetic Retinopathy Features Figure 5. Retinal Vein Occlusion Features Figure 6. Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacy Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Others Case Studies Figure 10. Retinal Disease Therapeutics Report Years Considered Figure 11. Global Retinal Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Retinal Disease Therapeutics Market Share by Regions: 2020 VS 2026 Figure 13. Global Retinal Disease Therapeutics Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Retinal Disease Therapeutics Market Share by Players in 2019 Figure 16. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2019 Figure 18. North America Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Asia-Pacific Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 29. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 31. Santen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020) Figure 33. Bottom-up and Top-down Approaches for This Report Figure 34. Data Triangulation Figure 35. Key Executives Interviewed

Merck Novartis Allergan Roche Regeneron Santen